Objectives:This study aimed to translate the revised 17-item Diabetes Distress Scale(DDS17,2017)into mandarin(simplified)Chinese and validate the Chinese version of DDS17(C-DDS17,2021)among adult patients with type 2 ...Objectives:This study aimed to translate the revised 17-item Diabetes Distress Scale(DDS17,2017)into mandarin(simplified)Chinese and validate the Chinese version of DDS17(C-DDS17,2021)among adult patients with type 2 diabetes in China.Methods:A scale translation and cross-sectional validation study was conducted.The DDS17 was translated into mandarin(simplified)Chinese through a five-step process:authorization,forward translation,synthesis,back translation,and amendment.During this session,59 patients assessed the understandability and readability of the translated scale.From June 7 to September 4,2021,a cross-sectional study that adhered to the COSMIN checklist was conducted with 400 individuals with type 2 diabetes from three Class A tertiary comprehensive hospitals in Beijing,China.The content,construct,convergent,discriminant validity,and reliability(Cronbach’s a coefficient and item-total correlation coefficients)of the C-DDS17 were evaluated.This study was a part of a project registered in the Chinese Clinical Trial Registry(no.ChiCTR2100047071).Results:Among the participants,33.3%(133/400)of them experienced moderate to high diabetes distress.The content validity indices of the C-DDS17 equaled 1.00.The scale yielded a four-factor structure.The average variances extracted were 0.42e0.57,which was lower than squared correla-tions.Cronbach’s a coefficient was 0.88 for the overall scale and ranged from 0.76 to 0.81 for sub-scales.Corrected item-total correlation coefficients ranged from 0.42 to 0.61.The eighth item(“Feeling that I am often failing with my diabetes routine”)was better fit to physician distress than regimen distress but had little influence on the validation results.Conclusions:The C-DDS17 is a reliable and valid instrument for assessing diabetes distress in patients with type 2 diabetes.It is a promising instrument for early identification and management of diabetes distress in clinical practice and trials.展开更多
文摘Objectives:This study aimed to translate the revised 17-item Diabetes Distress Scale(DDS17,2017)into mandarin(simplified)Chinese and validate the Chinese version of DDS17(C-DDS17,2021)among adult patients with type 2 diabetes in China.Methods:A scale translation and cross-sectional validation study was conducted.The DDS17 was translated into mandarin(simplified)Chinese through a five-step process:authorization,forward translation,synthesis,back translation,and amendment.During this session,59 patients assessed the understandability and readability of the translated scale.From June 7 to September 4,2021,a cross-sectional study that adhered to the COSMIN checklist was conducted with 400 individuals with type 2 diabetes from three Class A tertiary comprehensive hospitals in Beijing,China.The content,construct,convergent,discriminant validity,and reliability(Cronbach’s a coefficient and item-total correlation coefficients)of the C-DDS17 were evaluated.This study was a part of a project registered in the Chinese Clinical Trial Registry(no.ChiCTR2100047071).Results:Among the participants,33.3%(133/400)of them experienced moderate to high diabetes distress.The content validity indices of the C-DDS17 equaled 1.00.The scale yielded a four-factor structure.The average variances extracted were 0.42e0.57,which was lower than squared correla-tions.Cronbach’s a coefficient was 0.88 for the overall scale and ranged from 0.76 to 0.81 for sub-scales.Corrected item-total correlation coefficients ranged from 0.42 to 0.61.The eighth item(“Feeling that I am often failing with my diabetes routine”)was better fit to physician distress than regimen distress but had little influence on the validation results.Conclusions:The C-DDS17 is a reliable and valid instrument for assessing diabetes distress in patients with type 2 diabetes.It is a promising instrument for early identification and management of diabetes distress in clinical practice and trials.
